These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 16511588)

  • 21. Cracking the estrogen receptor's posttranslational code in breast tumors.
    Le Romancer M; Poulard C; Cohen P; Sentis S; Renoir JM; Corbo L
    Endocr Rev; 2011 Oct; 32(5):597-622. PubMed ID: 21680538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of estrogen receptor messenger ribonucleic acid in normal and ovariectomized rat bone].
    Li W; Huang F; Tan Y
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):312-4. PubMed ID: 8745482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
    Windahl SH; Hollberg K; Vidal O; Gustafsson JA; Ohlsson C; Andersson G
    J Bone Miner Res; 2001 Aug; 16(8):1388-98. PubMed ID: 11499861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer].
    Hanstein B; Beckmann MW; Bender HG
    Zentralbl Gynakol; 2002 Jan; 124(1):17-9. PubMed ID: 11873309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity.
    Kim HI; Kim T; Kim JE; Lee J; Heo J; Lee NR; Kim NJ; Inn KS
    Int J Oncol; 2015 Jul; 47(1):280-6. PubMed ID: 25964080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxysterols and phytosterols in human health.
    Massaad C; Iuliano L; Lizard G
    Chem Phys Lipids; 2017 Oct; 207(Pt B):49-50. PubMed ID: 28800872
    [No Abstract]   [Full Text] [Related]  

  • 29. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems.
    Kuiper GG; Shughrue PJ; Merchenthaler I; Gustafsson JA
    Front Neuroendocrinol; 1998 Oct; 19(4):253-86. PubMed ID: 9799586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity.
    Vasudevan N; Ogawa S; Pfaff D
    Physiol Rev; 2002 Oct; 82(4):923-44. PubMed ID: 12270948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptors: therapies targeted to receptor subtypes.
    Nilsson S; Gustafsson JÅ
    Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptors and endothelium.
    Arnal JF; Fontaine C; Billon-Galés A; Favre J; Laurell H; Lenfant F; Gourdy P
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1506-12. PubMed ID: 20631350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports.
    El Kihel L
    Steroids; 2012 Jan; 77(1-2):10-26. PubMed ID: 22037250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of estrogen effects on the endothelium: an overview.
    Chakrabarti S; Morton JS; Davidge ST
    Can J Cardiol; 2014 Jul; 30(7):705-12. PubMed ID: 24252499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Newly discovered estrogen receptor. New therapeutic possibilities in postmenopausal symptoms, osteoporosis, cancer of the breast and prostate].
    Enmark E; Gustafsson JA
    Lakartidningen; 1998 Apr; 95(17):1945-9. PubMed ID: 9604640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.
    Adams JY; Leav I; Lau KM; Ho SM; Pflueger SM
    Prostate; 2002 Jun; 52(1):69-81. PubMed ID: 11992621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen receptor and selective estrogen receptor modulators (SERMs)].
    Shioi A; Nishizawa Y
    Nihon Rinsho; 1999 May; 57(5):1199-207. PubMed ID: 10361456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.